Literature DB >> 10209492

Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease.

G Dijkstra1, H Moshage, H M van Dullemen, A de Jager-Krikken, A T Tiebosch, J H Kleibeuker, P L Jansen, H van Goor.   

Abstract

Nitric oxide (NO) and reactive oxygen species (ROS) are important mediators in the pathogenesis of inflammatory bowel disease (IBD). NO in IBD can be either harmful or protective. NO can react with superoxide anions (O2.-), yielding the toxic oxidizing agent peroxynitrite (ONOO-). Peroxynitrite induces nitration of tyrosine residues (nitrotyrosine), leading to changes of protein structure and function. The aim of this study was to identify the cellular source of inducible nitric oxide synthase (iNOS) and to localize superoxide anion-producing cells in mucosal biopsies from patients with active IBD. Additional studies were performed to look at nitrotyrosine formation as a measure of peroxynitrite-mediated tissue damage. For this, antibodies against iNOS, endothelial NOS (eNOS), and nitrotyrosine were used. ROS-producing cells were detected cytochemically. Inflamed mucosa of patients with active IBD showed intense iNOS staining in the epithelial cells. iNOS could not be detected in non-inflamed mucosa of IBD patients and control subjects. eNOS was present in blood vessels, without any difference in the staining intensity between IBD patients and control subjects. ROS-producing cells were increased in the lamina propria of IBD patients; a fraction of these cells were CD15-positive. Nitrotyrosine formation was found on ROS-positive cells. These results show that iNOS is induced in epithelial cells from patients with active ulcerative colitis or Crohn's disease. Nitration of proteins was detected only on the ROS-producing cells at some distance from the iNOS-producing epithelial cells. These findings indicate that tissue damage during active inflammation in IBD patients is probably more related to ROS-producing cells than to NO. One may speculate that NO has a protective role when during active inflammation other mucosal defence systems are impaired.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10209492     DOI: 10.1002/(SICI)1096-9896(199812)186:4<416::AID-PATH201>3.0.CO;2-U

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  42 in total

Review 1.  Peroxynitrite and inflammatory bowel disease.

Authors:  D M McCafferty
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

2.  Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn's disease and ulcerative colitis.

Authors:  A Sturm; A Z A Leite; S Danese; K A Krivacic; G A West; S Mohr; J W Jacobberger; C Fiocchi
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

3.  Rectal nitric oxide as biomarker in the treatment of inflammatory bowel disease: responders versus nonresponders.

Authors:  Tryggve Ljung; Sofie Lundberg; Mark Varsanyi; Catharina Johansson; Peter T Schmidt; Max Herulf; Jon O Lundberg; Per M Hellstrom
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

4.  Salmonella enterica serovar typhimurium-dependent regulation of inducible nitric oxide synthase expression in macrophages by invasins SipB, SipC, and SipD and effector SopE2.

Authors:  B J Cherayil; B A McCormick; J Bosley
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 5.  Inorganic nitrite therapy: historical perspective and future directions.

Authors:  Christopher G Kevil; Gopi K Kolluru; Christopher B Pattillo; Tony Giordano
Journal:  Free Radic Biol Med       Date:  2011-05-04       Impact factor: 7.376

6.  Colorectal carcinoma development in inducible nitric oxide synthase-deficient mice with dextran sulfate sodium-induced ulcerative colitis.

Authors:  Darren N Seril; Jie Liao; Guang-Yu Yang
Journal:  Mol Carcinog       Date:  2007-05       Impact factor: 4.784

Review 7.  Overview of cytokines and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel diseases.

Authors:  Imene Soufli; Ryma Toumi; Hayet Rafa; Chafia Touil-Boukoffa
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-08-06

Review 8.  iNOS expression in oral and gastrointestinal tract mucosa.

Authors:  Nurullah Keklikoglu; Meltem Koray; Humeyra Kocaelli; Sevtap Akinci
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

9.  Epithelial cell TGFβ signaling induces acute tubular injury and interstitial inflammation.

Authors:  Madeleine E Gentle; Shaolin Shi; Ilse Daehn; Taoran Zhang; Haiying Qi; Liping Yu; Vivette D D'Agati; Detlef O Schlondorff; Erwin P Bottinger
Journal:  J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 10.121

10.  Stability and reactivity of 2-nitrosoamino-3,8-dimethylimidazo[4,5-f]quinoxaline.

Authors:  Vijaya M Lakshmi; Fong Fu Hsu; Herman A J Schut; Terry V Zenser
Journal:  Chem Res Toxicol       Date:  2006-02       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.